GLP-1 medications have rapidly accelerated this challenge, becoming one of the fastest-growing and most expensive line items in employer health plans
The identified glutathione-related pathways provide potential therapeutic targets for alleviating oxidative stress-induced hippocampal injury in SAE, offering new insights for the clinical management of SAE-related neurological damage
and Route of Administration: Subcutaneous and Oral) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035 GLP-1 Analogues Market Outlook The global GLP-1 analogues market size was valued at US$ 51.6 Bn in 2024 and is projected to reach US$ 211.8 Bn by 2035, expanding at a CAGR of 13.7% from 2025 to 2035
We expect Lilly to partly elevate capacity constraints for Mounjaro and Zepbound in the second half of the year, Conover says
Serious Health Complications Linked to Zepbound Some Zepbound patients in West Virginia have reported having serious side effects and health complications
Cipolli, C